Developer docs
API playgroundTry for free, no card

Search company profiles

Yunu

Full company profile

uuid0006cka

Namestring
Yunu
Legal namestring
Yunu, Inc.
Websiteurl
yunu.io
Company typeenum
Private
Founded yearint
2022
Descriptiontext

Yunu is a privately-held med-tech company that provides a cloud-based clinical trial imaging platform serving cancer centers, pharmaceutical sponsors, and contract research organizations (CROs). The company was formally established in 2022 around proprietary imaging technology originally developed at Massachusetts General Hospital by Dr. Gordon Harris (now Yunu's CSO), with corporate headquarters in Cary, North Carolina. According to company-reported metrics, Yunu manages more than 5,000 active clinical trials across 8,000+ sites globally, serves 400+ life sciences companies, and holds over 25% share of imaging trials listed on clinicaltrials.gov — positioning it as a category leader in oncology trial imaging. The platform serves over 3,000 users across radiology, oncology, and trial roles, with named flagship customers including VCU Massey Comprehensive Cancer Center, Huntsman Cancer Institute / University of Utah, Medical College of Wisconsin, Dana-Farber/Harvard Cancer Center, and Massachusetts General Hospital.

The Yunu Platform delivers protocol-guided imaging workflows enforcing 30+ major response criteria (including RECIST, Lugano, and RANO) with over 300 trial-specific variants, real-time imaging dashboards, immutable audit trails for ICH E6(R3) compliance, and a Universal Integration Portal connecting to downstream EDC systems. The product portfolio includes purpose-built modules: Yunuverse (a connected network enabling cross-institution worklist sharing and reader access), De-ID & Export (site-to-sponsor anonymization), eCRF Builder (sponsor study configuration), Custom Dashboards, and segment-specific deployments for Cancer Centers and Sponsors/CROs. Yunu maintains 21 CFR Part 11, HITRUST CSF, SOC 2 Type II, HIPAA, and GDPR certifications, and reports reducing imaging error rates from 25-50% to under 3% post-adoption while cutting turnaround times from weeks to under 48 hours.

Yunu monetizes through annual enterprise SaaS subscriptions sold via direct field sales, with pricing quote-based and not publicly disclosed. Go-to-market combines relationship-based enterprise selling to NCI-designated cancer centers and large pharma sponsors with a heavy conference presence at SCOPE, ASCO, AACR, JPM, and DPHARM. The company has raised two funding rounds — an institutional round led by First Analysis in September 2022 and an oversubscribed round led by Spring Mountain Capital in May 2025 — both with undisclosed amounts. The leadership team is led by CEO Jeffrey Sorenson (co-founder) with a full C-suite including CTO Gael Kuhn, CMO Lindsay Fleming, CCO Patrick McNamara, and CSO Dr. Gordon Harris. Strategic integration partnerships span Veeva, Florence Healthcare, IgniteData, WCG, and Zelta by Merative, embedding Yunu into the broader eClinical ecosystem.

Short descriptiontext

Yunu is a cloud-based clinical trial imaging platform serving cancer centers, pharmaceutical sponsors, and CROs with protocol-guided workflows, real-time dashboards, and ICH E6(R3)-compliant audit tools across 5,000+ trials and 8,000+ sites globally.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersCary, United States
HQ citystring
Cary
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
clinical trial imaging software, medical imaging workflow platform, clinical trial imaging management, oncology imaging SaaS, imaging core lab software
Industry4 codes
PRIMARYHLAGAJAM
Clinical Trial Informatics (EDC/CTMS/eCOA/eTMF)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Life Science Software & Informatics (LIMS/ELN/Bioinformatics)
SECONDARYHLACALAG
AI Orchestration & Imaging Analytics Platforms (Model Management/Triage)
Healthcare & Life Sciences/Digital Health & Health IT/Medical Imaging Informatics (PACS/RIS/VNA) & Radiology IT
SECONDARYHLACAOAJ
Site & Investigator Platforms (Site Payments, Feasibility, Activation)
Healthcare & Life Sciences/Digital Health & Health IT/Clinical Trials & Research Informatics (eCOA/ePRO/EDC)
SECONDARYHLACALAL
Quality, Peer Review & Compliance Tools (MQSA/ACR/QA)
Healthcare & Life Sciences/Digital Health & Health IT/Medical Imaging Informatics (PACS/RIS/VNA) & Radiology IT
NAICS code3 codes
  • Software Publishers513210
  • Computing Infrastructure Providers, Data Processing, Web Hosting, and Related Services5182
  • Scientific Research and Development Services5417
SIC code1 code
  • Services-Commercial Physical & Biological Research8731
Product category
Clinical Trial Imaging Software
Social media profiles2 records
GTM motion3 records

Each record includes

Type, Description, Source

Revenue model1 record
1SaaS Platform Subscription
TypeSubscription Recurring
Description

Cloud-based platform provided as subscription service to cancer centers, sponsors, and CROs. Delivers imaging workflow management, protocol guidance, and compliance tools as a service with tiered access based on organization type and scale.

yunu.io
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels2 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components4 values
Personnel, Technology or R&D, Marketing or Sales, Operations
Pricing details1 tier
1Enterprise SaaS subscription model
ModelSubscriptionBilling cadenceAnnual
Notes

Pricing not publicly disclosed; requires contact with sales team for quote

yunu.io
GTM typeB2B
B2B
Offering typeSoftware
Software
Brand1 record
1Yunuverse
Description

A connected network of imaging stakeholders that allows trial worklists to move seamlessly between institutions, connecting radiologists, sites, sponsors, and CROs.

yunu.io
Core offering1 text field

Yunu operates a cloud-based, end-to-end clinical trial imaging platform that harmonizes imaging workflows, data, and compliance from initial scan through trial submission. The platform delivers protocol-guided workflows for 30+ major response criteria with 300+ trial-specific variants, real-time imaging dashboards, immutable audit trails meeting ICH E6(R3), and a connected reader network (Yunuverse). It is offered as a SaaS subscription to cancer centers, pharmaceutical sponsors, and CROs with role-based access and integrations to leading eClinical platforms including Florence Healthcare, IgniteData, Veeva, and Zelta by Merative.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 7 values shown
  • Error rates reduced from 25-50% to under 3% after Yunu adoption
+6 more records
Product overview1 text field

Yunu is a cloud-based clinical trial imaging platform offering a unified, end-to-end solution for managing imaging workflows across sites, sponsors, and CROs. The core Yunu Platform serves as the foundational system, supporting protocol-guided reads for 30+ response criteria and delivering ICH E6(R3) compliant, audit-ready imaging data. The portfolio includes purpose-specific modules: Yunu De-ID & Export (anonymization and site-to-sponsor data sharing), Yunuverse (networked reader collaboration), and Yunu for Sponsors/CROs and Yunu for Cancer Centers (segment-specific deployments). Recent additions include eCRF Builder, Custom Dashboards, and Universal Integration Portal enabling sponsor-level study configuration and integration with eClinical ecosystems. The platform integrates with leading eClinical tools including Florence Healthcare, IgniteData, Veeva, and Zelta by Merative.

Product and service9 records
1Yunu Platform
CategoryClinical Trial Imaging Software
Description

End-to-end cloud-based clinical trial imaging platform that harmonizes imaging workflows, data, and compliance from initial scan through trial submission. Trusted by sponsors and cancer centers to deliver speed, accuracy, and ICH E6(R3) compliance. Supports protocol-guided reads for 30+ major response criteria with over 300 trial-specific variants.

2Yunu De-ID & Export
CategoryClinical Trial Imaging Software Add-on
Description

Add-on capability enabling sites to anonymize and export trial images and results directly from existing workflow. Provides streamlined de-identification, role-based permissions, and Subject ID mapping for controlled site-to-sponsor data handoff with greater traceability and less manual effort.

3Yunu eCRF Builder
CategoryClinical Trial Imaging Software Module
Description

Enables pharma sponsors to configure electronic case report forms and studies in minutes, ensuring imaging consistency and delivering data directly to primary systems.

4Yunu Custom Dashboards
CategoryClinical Trial Imaging Software Module
Description

Real-time configurable dashboards providing sponsors, CROs, and imaging stakeholders live visibility into read status, site compliance, lesion tracking, imaging queries, and resolution times across all trials and sites.

5Yunu Universal Integration Portal
CategoryClinical Trial Imaging Software Module
Description

Integration capability enabling streamlined workflows and connectivity with primary systems for site staff, reducing manual data entry and coordination overhead.

6Yunuverse
CategoryClinical Trial Imaging Network
Description

Connected network of imaging stakeholders (readers, radiologists, coordinators) that allows trial worklists to move seamlessly between institutions. Enables cross-institution collaboration, eliminates backlogs and delays, and provides access to trained readers, technologists, and protocol experts on demand.

7Yunu for Sponsors & CROs
CategoryClinical Trial Imaging Platform for Sponsors and CROs
Description

Trial management solution for sponsors and CROs enabling trial launch in 30 minutes, automated site data collection, enforced accuracy, outsourced reads, BICR, and central review with a click. Provides real-time dashboards, traceability, and ICH E6(R3) compliance.

8Yunu for Cancer Centers
CategoryClinical Trial Imaging Platform for Cancer Centers
Description

Site-level trial imaging solution reducing image management effort by 80%. Unifies reader worklists and structured outputs, automates QC, enforces 30+ imaging response criteria, and provides access to trained readers, technologists, and protocol experts.

9Yunu Central Review Workflow Extension
CategoryClinical Trial Imaging Software Extension
Description

Extension of the Yunu Platform that brings sponsor-specific requirements into workflow logic and creates a unified environment for sites and sponsors with aligned standards, controlled visibility, and consistent execution. Reduces coordination layers and overhead for central review workflows.

Scale indicator12 records

Each record includes

Type, Value, Description, Source

Partnership4 partners
1WCG
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2025-02-10
Description

Yunu partnered with WCG (a global leader in clinical trial solutions) and IgniteData to transform clinical trial imaging services. WCG uses Yunu in support of their imaging services, providing integrated real-time platform for WCG's imaging workflows.

clinicaltrialvanguard.com
Strategic tierCoreTypeTechnology or Integration
Description

Integration partnership with Florence Healthcare, a leading eClinical platform. Florence integration logo appears on Yunu partners page indicating active integration to ensure imaging fits seamlessly into broader clinical trial ecosystem.

Strategic tierCoreTypeTechnology or Integration
Description

Strategic partnership announced in February 2025 to improve clinical trial imaging services through an integrated, real-time platform. IgniteData selected Yunu as imaging partner for Top 50 Pharma. Partnership enables seamless EHR-to-EDC integration with imaging data.

Strategic tierCoreTypeTechnology or Integration
Description

Integration partnership with Veeva Systems, a leading cloud software company for life sciences. Veeva integration logo appears on Yunu partners page indicating active integration.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

Veeva is a leading cloud software provider for life sciences with Vault EDC and CTMS products. It is a strategic integration partner of Yunu but also a broad incumbent whose platform could expand into imaging workflows.

TypeEmerging player
Description

Florence Healthcare provides the eBinders eClinical platform connecting sponsors, CROs, and sites. It is an integration partner of Yunu but also an adjacent workflow provider in site-centric clinical trial operations.

TypeBroad incumbent
Description

Parexel is a global CRO with clinical trial imaging and central imaging review services. It competes broadly with Yunu in imaging-enabled clinical trial delivery for pharma and biotech sponsors.

TypeBroad incumbent
Description

ICON is a global CRO offering clinical trial services including imaging core lab capabilities via its Medical Imaging division. It is a broad incumbent that can bundle imaging services into full-service CRO contracts, competing with Yunu for sponsor business.

5Oracle Health Sciences
TypeBroad incumbent
Description

Oracle Health Sciences offers the Siebel CTMS and clinical trial platforms used by large pharma. It competes broadly with Yunu in trial data management and EDC, while Yunu specializes in imaging.

TypeDirect peer
Description

Imaging Endpoints is a specialized oncology imaging core lab providing central review and imaging services for clinical trials. It competes directly with Yunu's central review and BICR offerings for oncology trial sponsors.

TypeBroad incumbent
Description

Medidata provides the Rave clinical trial platform used by most large pharma sponsors and offers imaging and EDC capabilities. It competes with Yunu at the sponsor/CRO level as part of a broader eClinical suite, while Yunu specializes in imaging-specific workflows.

TypeDirect peer
Description

Clario is a leading clinical trial technology and imaging endpoint company formed from the merger of ERT and Bioclinica. It directly competes with Yunu in clinical trial imaging workflows, central review, and eCOA/ePRO for pharma and CRO customers.

TypeDirect peer
Description

Median Technologies provides iCRO imaging services and AI-based imaging analytics for oncology clinical trials. It is a direct competitor in the oncology trial imaging workflow and central review market.

TypeDirect peer
Description

Calyx (formerly Calyx Clinical Trial Solutions, spun out of ICON) provides imaging management, EDC, and clinical trial technology services. It directly competes with Yunu in trial imaging management for pharma and CRO customers.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat6 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers5 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

Integration4 records

Each record includes

Title, Type, Description, Source

AI capability1 record

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature7 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles12 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance5 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds1 record

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors1 record

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Yunu

Clinical Trial Imaging Softwareyunu.io

Yunu is a cloud-based clinical trial imaging platform serving cancer centers, pharmaceutical sponsors, and CROs with protocol-guided workflows, real-time dashboards, and ICH E6(R3)-compliant audit tools across 5,000+ trials and 8,000+ sites globally.

What Yunu does

Yunu is a privately-held med-tech company that provides a cloud-based clinical trial imaging platform serving cancer centers, pharmaceutical sponsors, and contract research organizations (CROs). The company was formally established in 2022 around proprietary imaging technology originally developed at Massachusetts General Hospital by Dr. Gordon Harris (now Yunu's CSO), with corporate headquarters in Cary, North Carolina. According to company-reported metrics, Yunu manages more than 5,000 active clinical trials across 8,000+ sites globally, serves 400+ life sciences companies, and holds over 25% share of imaging trials listed on clinicaltrials.gov — positioning it as a category leader in oncology trial imaging. The platform serves over 3,000 users across radiology, oncology, and trial roles, with named flagship customers including VCU Massey Comprehensive Cancer Center, Huntsman Cancer Institute / University of Utah, Medical College of Wisconsin, Dana-Farber/Harvard Cancer Center, and Massachusetts General Hospital.

The Yunu Platform delivers protocol-guided imaging workflows enforcing 30+ major response criteria (including RECIST, Lugano, and RANO) with over 300 trial-specific variants, real-time imaging dashboards, immutable audit trails for ICH E6(R3) compliance, and a Universal Integration Portal connecting to downstream EDC systems. The product portfolio includes purpose-built modules: Yunuverse (a connected network enabling cross-institution worklist sharing and reader access), De-ID & Export (site-to-sponsor anonymization), eCRF Builder (sponsor study configuration), Custom Dashboards, and segment-specific deployments for Cancer Centers and Sponsors/CROs. Yunu maintains 21 CFR Part 11, HITRUST CSF, SOC 2 Type II, HIPAA, and GDPR certifications, and reports reducing imaging error rates from 25-50% to under 3% post-adoption while cutting turnaround times from weeks to under 48 hours.

Yunu monetizes through annual enterprise SaaS subscriptions sold via direct field sales, with pricing quote-based and not publicly disclosed. Go-to-market combines relationship-based enterprise selling to NCI-designated cancer centers and large pharma sponsors with a heavy conference presence at SCOPE, ASCO, AACR, JPM, and DPHARM. The company has raised two funding rounds — an institutional round led by First Analysis in September 2022 and an oversubscribed round led by Spring Mountain Capital in May 2025 — both with undisclosed amounts. The leadership team is led by CEO Jeffrey Sorenson (co-founder) with a full C-suite including CTO Gael Kuhn, CMO Lindsay Fleming, CCO Patrick McNamara, and CSO Dr. Gordon Harris. Strategic integration partnerships span Veeva, Florence Healthcare, IgniteData, WCG, and Zelta by Merative, embedding Yunu into the broader eClinical ecosystem.

Yunu firmographics

Firmographics
Name
Yunu
Legal name
Yunu, Inc.
Website
https://yunu.io
Company type
Private
Founded year
2022
Operating status
Operating
Headcount range
11–50 employees
Short description
Yunu is a cloud-based clinical trial imaging platform serving cancer centers, pharmaceutical sponsors, and CROs with protocol-guided workflows, real-time dashboards, and ICH E6(R3)-compliant audit tools across 5,000+ trials and 8,000+ sites globally.
Ownership category
akta.pro rank

Yunu industry classification

Industry
Product category
Clinical Trial Imaging Software
NAICS
Software Publishers (513210), Computing Infrastructure Providers, Data Processing, Web Hosting, and Related Services (5182), Scientific Research and Development Services (5417)
SIC
Services-Commercial Physical & Biological Research (8731)
akta.pro industry
PRIMARYHLAGAJAM
Clinical Trial Informatics (EDC/CTMS/eCOA/eTMF)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Life Science Software & Informatics (LIMS/ELN/Bioinformatics)
SECONDARYHLACALAG
AI Orchestration & Imaging Analytics Platforms (Model Management/Triage)
Healthcare & Life Sciences/Digital Health & Health IT/Medical Imaging Informatics (PACS/RIS/VNA) & Radiology IT
SECONDARYHLACAOAJ
Site & Investigator Platforms (Site Payments, Feasibility, Activation)
Healthcare & Life Sciences/Digital Health & Health IT/Clinical Trials & Research Informatics (eCOA/ePRO/EDC)
SECONDARYHLACALAL
Quality, Peer Review & Compliance Tools (MQSA/ACR/QA)
Healthcare & Life Sciences/Digital Health & Health IT/Medical Imaging Informatics (PACS/RIS/VNA) & Radiology IT

Keywords

  • Clinical trial imaging software
  • Medical imaging workflow platform
  • Clinical trial imaging management
  • Oncology imaging SaaS
  • Imaging core lab software

Where Yunu is headquartered

Location

Headquarters

HQ city
Cary
HQ country
United States
HQ region
North America

Offices1 record

Markets served

Yunu business model

Business model
GTM type
B2B
Offering type
Software
Cost components
Personnel, Technology or R&D, Marketing or Sales, Operations

Revenue model

  1. SaaS Platform Subscription: Cloud-based platform provided as subscription service to cancer centers, sponsors, and CROs. Delivers imaging workflow management, protocol guidance, and compliance tools as a service with tiered access based on organization type and scale.

Pricing tiers

ModelBillingPrice
SubscriptionAnnualEnterprise SaaS subscription model

Go-to-market motion3 records

Distribution channels2 records

Marketing channels5 records

Yunu product offering

Product offering

Core offering

Yunu operates a cloud-based, end-to-end clinical trial imaging platform that harmonizes imaging workflows, data, and compliance from initial scan through trial submission. The platform delivers protocol-guided workflows for 30+ major response criteria with 300+ trial-specific variants, real-time imaging dashboards, immutable audit trails meeting ICH E6(R3), and a connected reader network (Yunuverse). It is offered as a SaaS subscription to cancer centers, pharmaceutical sponsors, and CROs with role-based access and integrations to leading eClinical platforms including Florence Healthcare, IgniteData, Veeva, and Zelta by Merative.

Product overview

Yunu is a cloud-based clinical trial imaging platform offering a unified, end-to-end solution for managing imaging workflows across sites, sponsors, and CROs. The core Yunu Platform serves as the foundational system, supporting protocol-guided reads for 30+ response criteria and delivering ICH E6(R3) compliant, audit-ready imaging data. The portfolio includes purpose-specific modules: Yunu De-ID & Export (anonymization and site-to-sponsor data sharing), Yunuverse (networked reader collaboration), and Yunu for Sponsors/CROs and Yunu for Cancer Centers (segment-specific deployments). Recent additions include eCRF Builder, Custom Dashboards, and Universal Integration Portal enabling sponsor-level study configuration and integration with eClinical ecosystems. The platform integrates with leading eClinical tools including Florence Healthcare, IgniteData, Veeva, and Zelta by Merative.

Differentiator

Problem solved

Functional benefit

Brands

  • Yunuverse: A connected network of imaging stakeholders that allows trial worklists to move seamlessly between institutions, connecting radiologists, sites, sponsors, and CROs.

Products and services

  • Yunu Platform End-to-end cloud-based clinical trial imaging platform that harmonizes imaging workflows, data, and compliance from initial scan through trial submission. Trusted by sponsors and cancer centers to deliver speed, accuracy, and ICH E6(R3) compliance. Supports protocol-guided reads for 30+ major response criteria with over 300 trial-specific variants.
  • Yunu De-ID & Export Add-on capability enabling sites to anonymize and export trial images and results directly from existing workflow. Provides streamlined de-identification, role-based permissions, and Subject ID mapping for controlled site-to-sponsor data handoff with greater traceability and less manual effort.
  • Yunu eCRF Builder Enables pharma sponsors to configure electronic case report forms and studies in minutes, ensuring imaging consistency and delivering data directly to primary systems.
  • Yunu Custom Dashboards Real-time configurable dashboards providing sponsors, CROs, and imaging stakeholders live visibility into read status, site compliance, lesion tracking, imaging queries, and resolution times across all trials and sites.
  • Yunu Universal Integration Portal Integration capability enabling streamlined workflows and connectivity with primary systems for site staff, reducing manual data entry and coordination overhead.
  • Yunuverse Connected network of imaging stakeholders (readers, radiologists, coordinators) that allows trial worklists to move seamlessly between institutions. Enables cross-institution collaboration, eliminates backlogs and delays, and provides access to trained readers, technologists, and protocol experts on demand.
  • Yunu for Sponsors & CROs Trial management solution for sponsors and CROs enabling trial launch in 30 minutes, automated site data collection, enforced accuracy, outsourced reads, BICR, and central review with a click. Provides real-time dashboards, traceability, and ICH E6(R3) compliance.
  • Yunu for Cancer Centers Site-level trial imaging solution reducing image management effort by 80%. Unifies reader worklists and structured outputs, automates QC, enforces 30+ imaging response criteria, and provides access to trained readers, technologists, and protocol experts.
  • Yunu Central Review Workflow Extension Extension of the Yunu Platform that brings sponsor-specific requirements into workflow logic and creates a unified environment for sites and sponsors with aligned standards, controlled visibility, and consistent execution. Reduces coordination layers and overhead for central review workflows.

Quantifiable outcome

  • Error rates reduced from 25-50% to under 3% after Yunu adoption
  • +6 more outcomes

Companies that use Yunu

Customer profile

Named customers5 records

Segments3 records

Ideal customer profiles2 records

Yunu technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Integration4 records

AI capability1 record

Feature7 records

Yunu partnerships and signals

Strategic signal

Partnerships

Four partnerships are on record, tiered core.

  • WCGcoreStrategic or Co-development Partner · 10 February 2025Yunu partnered with WCG (a global leader in clinical trial solutions) and IgniteData to transform clinical trial imaging services. WCG uses Yunu in support of their imaging services, providing integrated real-time platform for WCG's imaging workflows.
  • Florence HealthcarecoreTechnology or IntegrationIntegration partnership with Florence Healthcare, a leading eClinical platform. Florence integration logo appears on Yunu partners page indicating active integration to ensure imaging fits seamlessly into broader clinical trial ecosystem.
  • IgniteDatacoreTechnology or IntegrationStrategic partnership announced in February 2025 to improve clinical trial imaging services through an integrated, real-time platform. IgniteData selected Yunu as imaging partner for Top 50 Pharma. Partnership enables seamless EHR-to-EDC integration with imaging data.
  • VeevacoreTechnology or IntegrationIntegration partnership with Veeva Systems, a leading cloud software company for life sciences. Veeva integration logo appears on Yunu partners page indicating active integration.

Scale indicators12 records

Recent moves6 records

Expansion highlights5 records

Yunu competitors and assessment

Company assessment

Broad incumbents

  • Veeva Systems: Veeva is a leading cloud software provider for life sciences with Vault EDC and CTMS products. It is a strategic integration partner of Yunu but also a broad incumbent whose platform could expand into imaging workflows.
  • Parexel: Parexel is a global CRO with clinical trial imaging and central imaging review services. It competes broadly with Yunu in imaging-enabled clinical trial delivery for pharma and biotech sponsors.
  • ICON plc: ICON is a global CRO offering clinical trial services including imaging core lab capabilities via its Medical Imaging division. It is a broad incumbent that can bundle imaging services into full-service CRO contracts, competing with Yunu for sponsor business.
  • Oracle Health Sciences: Oracle Health Sciences offers the Siebel CTMS and clinical trial platforms used by large pharma. It competes broadly with Yunu in trial data management and EDC, while Yunu specializes in imaging.
  • Medidata (Dassault Systèmes): Medidata provides the Rave clinical trial platform used by most large pharma sponsors and offers imaging and EDC capabilities. It competes with Yunu at the sponsor/CRO level as part of a broader eClinical suite, while Yunu specializes in imaging-specific workflows.

Emerging players

  • Florence Healthcare: Florence Healthcare provides the eBinders eClinical platform connecting sponsors, CROs, and sites. It is an integration partner of Yunu but also an adjacent workflow provider in site-centric clinical trial operations.

Direct peers

  • Imaging Endpoints: Imaging Endpoints is a specialized oncology imaging core lab providing central review and imaging services for clinical trials. It competes directly with Yunu's central review and BICR offerings for oncology trial sponsors.
  • Clario: Clario is a leading clinical trial technology and imaging endpoint company formed from the merger of ERT and Bioclinica. It directly competes with Yunu in clinical trial imaging workflows, central review, and eCOA/ePRO for pharma and CRO customers.
  • Median Technologies: Median Technologies provides iCRO imaging services and AI-based imaging analytics for oncology clinical trials. It is a direct competitor in the oncology trial imaging workflow and central review market.
  • Calyx: Calyx (formerly Calyx Clinical Trial Solutions, spun out of ICON) provides imaging management, EDC, and clinical trial technology services. It directly competes with Yunu in trial imaging management for pharma and CRO customers.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

Yunu social profiles

Digital presence

Yunu compliance and trust

Trust signal

Compliance5 records

Yunu financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Yunu leadership team

Management profile

Number of profiles

Profiles12 records

Yunu funding detail

Funding detail

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Yunu M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Yunu

What does Yunu do?

Yunu operates a cloud-based, end-to-end clinical trial imaging platform that harmonizes imaging workflows, data, and compliance from initial scan through trial submission. The platform delivers protocol-guided workflows for 30+ major response criteria with 300+ trial-specific variants, real-time imaging dashboards, immutable audit trails meeting ICH E6(R3), and a connected reader network (Yunuverse). It is offered as a SaaS subscription to cancer centers, pharmaceutical sponsors, and CROs with role-based access and integrations to leading eClinical platforms including Florence Healthcare, IgniteData, Veeva, and Zelta by Merative.

Is Yunu a public or private company?

Yunu is a private company. It is classified as venture growth investor backed and is currently operating.

When was Yunu founded?

Yunu was founded in 2022. It employs 11 to 50 people.

Where is Yunu based?

Yunu is headquartered in Cary, United States, in the North America region.

How does Yunu make money?

One revenue line is on record: saaS Platform Subscription.

Who are Yunu's main competitors?

Broad incumbents on record are Veeva Systems, Parexel, ICON plc, Oracle Health Sciences and Medidata (Dassault Systèmes). Florence Healthcare is listed as an emerging player. Direct peers are Imaging Endpoints, Clario, Median Technologies and Calyx.

Does Yunu have an API?

No public API is recorded for Yunu.

What industry is Yunu in?

Yunu's product category is Clinical Trial Imaging Software. Its primary akta.pro industry code is HLAGAJAM, Clinical Trial Informatics (EDC/CTMS/eCOA/eTMF), with a secondary code of HLACALAG, AI Orchestration & Imaging Analytics Platforms (Model Management/Triage). Its NAICS code is 513210 and its SIC code is 8731.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
NewswireYunu Launches De-ID & Export to Simplify Site-to-Sponsor Trial Data SharingYunu announced De-ID & Export, an add-on to anonymize and export trial images and results from existing workflows. The capability supports trial, patient, and timepoint-level workflows with role-based permissions and Subject ID mapping. Yunu will exhibit at ASCO's Annual Meeting from May 30 to June 1.Healthcare IT TodayClinical Trials Imaging Innovator Yunu Raises Oversubscribed Funding Round Led by Spring Mountain CapitalYunu, a provider of clinical trials imaging solutions, secured funding led by Spring Mountain Capital to expand its growth and address industry-wide imaging accuracy issues. The company already manages over 5,000 oncology trials across major cancer centers and collaborates with numerous pharma companies.YunuClinical Trials Imaging Innovator Yunu Raises Oversubscribed Funding Round Led by Spring Mountain CapitalYunu, a clinical trials imaging platform, raised an oversubscribed funding round led by Spring Mountain Capital. The company serves over 5,000 active oncology trials across more than 25% of NCI-designated cancer centers. Yunu will demonstrate its capabilities at upcoming industry meetings.PharmiWeb.comClinical Trials Imaging Innovator Yunu Raises Oversubscribed Funding Round Led by Spring Mountain CapitalYunu, a clinical trials imaging platform, raised an oversubscribed funding round led by Spring Mountain Capital. The investment aims to accelerate its pharma sponsor and site network growth, with the company serving over 5,000 active oncology trials. Yunu will demonstrate its capabilities at upcoming industry meetings.MorningstarClinical Trials Imaging Innovator Yunu Raises Oversubscribed Funding Round Led by Spring Mountain CapitalYunu, a clinical trials imaging platform, raised an oversubscribed funding round led by Spring Mountain Capital. The investment aims to accelerate its pharma sponsor and site network growth, with the company serving over 5,000 active oncology trials. Yunu will demonstrate its capabilities at upcoming industry meetings.YahooClinical Trials Imaging Innovator Yunu Raises Oversubscribed Funding Round Led by Spring Mountain CapitalYunu secured an investment led by Spring Mountain Capital to accelerate its growth in the pharma sponsor and site network within the clinical trial imaging market. The funding aims to address industry-wide accuracy issues in imaging during oncology trials, potentially saving millions and reducing delays. Yunu plans to demonstrate its solutions at upcoming industry meetings.ClinicaltrialvanguardYunu Partnership with WCG and IgniteData Transforms Clinical Trial ImagingYunu partnered with WCG and IgniteData to provide a web-based imaging platform for clinical trials, reducing study staff time by 80% and cutting errors. The platform saves sponsors 200 days and $5 million on a phase two trial, and addresses 30-50% non-conformance in trial imaging assessments.MorningstarEHR-to-EDC Leader, IgniteData, Selects Yunu as Imaging Partner for Top 50 PharmaYunu and IgniteData announced a partnership to integrate Yunu's imaging workflow platform into IgniteData's Archer EHR-to-EDC application. The integration provides audit-ready imaging assessments for sponsors, addressing site errors that occur between 25-50% of the time. The companies will exhibit together at SCOPE 2025 in Orlando.Business InsiderYunu Extends Free Cancer Center Use of Platform for All Children’s Oncology Group Clinical TrialsYunu will extend free use of its clinical trial imaging platform to all Children's Oncology Group trials nationwide, waiving implementation and time-point fees. The initiative aims to ensure pediatric cancer hospitals have access to world-class imaging capabilities, with COG's 5-year survival rate at 80%.